A P-Selectin/CD62P Monoclonal Antibody (LYP-20), in Tandem with Flow Cytometry, Detects in vivo Activated Circulating Rat Platelets in Severe Vascular Trauma

Summary

P-selectin, also known as CD62P, GMP140 or PADGEM, is present in platelet a-granules and endothelial cell Weibel-Palade bodies and is very rapidly expressed on the surface of these cells on activation. In this study, an anti P-selectin monoclonal antibody (LYP20) was used, in tandem with flow cytometry, to identify activated platelets at the site of induced vascular trauma or in peripheral blood. Moreover, electron microscopy was performed to characterize sites of vascular trauma and quantify the number of adhering platelets. The same induced vascular trauma was observed to result into animals responding in 2 different ways (Group I, Group II) following the degree of platelet activation. Five rats, out of 14 with induced vascular trauma, had more than half of their circulating platelets expressing P-selectin when drawn at the site of the trauma (67.4% ± 3.44) or in peripheral blood (78.5% ± 2.5) (Group I). In the remaining 9 animals a much smaller proportion of circulating platelets expressed P-selectin when assayed from trauma sites (18% ± 3.34) or in peripheral blood (18.0% ± 4.30) (Group II). Enhanced P-selectin expression by circulating platelets in Group I, compared to Group II, appears to be linked to the degree of activated platelets adhering at sites of trauma (171 ± 15 × 10³ platelets versus 48 ± 31 × 10³ platelets per mm2). In the 5 control animals, that were not operated on, platelets expressing P-selectin when drawn at the site of a mock trauma (7.0% ± 1.84) or in the peripheral blood (11.2% ± 3.30) showed little activation. In addition, no platelet adhesion was seen on the vascular bed of these animals. Results from this study show that analysis of P-selectin (CD62P) expression, in circulating platelets, is a valuable and rapid marker of platelet activation following severe vascular trauma induced in rats. However, activated platelets were not detected to the same extent in the peripheral blood of all animals having undergone vascular trauma. It is conceivable that platelets, depending on the degree of activation, may be actively sequestered in organs and prevented from circulating. Alternatively, P-selectin may be rapidly endocytosed, or not expressed, by activated circulating platelets depending on the type of agonists implicated in vivo activation.

• References

• 1 Baumgartner HR, Hosang M. Platelets, platelet derived growth factor and arteriosclerosis. Experientia 1988; 44: 109-112
• 2 Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein Ilb-IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107-11114
• 3 McEver RP, Martin MN. A monoclonal an6tibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 1984; 259: 9799-9804
• 4 Nieuwenhuis HK, van Oosterhout JJG, Rozemmuller E, van Iwaarden F, Sixma JJ. Studies with a monoclonal antibody against activated platelets. Evicence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 1987; 70: 838-845
• 5 Febbraio M, Silverstein RL. Identification and characterization of LAMP-1 as an activation-dependent platelet surface glycoprotein. J Biol Chem 1990; 256: 18531-18537
• 6 Silverstein RL, Febbraio M. LAMP-2 is an activation-dependent platelet surface protein: Further evidence for platelet lysosomal membrane flow. J Cell Biol 1990; 111: 66a
• 7 Boukerche H, McGregor JL. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human platelet functions. Eur J Biochem 1988; 171: 383-392
• 8 McEver R. Selectins: Novel Receptors that Mediate Leukocyte Adhesion During Inflammation. Thromb and Haemost 1991; 65: 223-228
• 9 Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg MH, Furie B. A platelet alpha-granule membrane protein that is associated with the plasma membrane after activation. J Clin Invest 1986; 78: 130-137
• 10 McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet alpha-granule membrane protein is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989; 84: 92-99
• 11 Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990; 75: 550-554
• 12 Larsen E, Celi A, Gilberg GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989; 59: 305-312
• 13 Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434
• 14 Johnston GI, Cook RG, McEver RP. Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation. Cell 1989; 56: 1033-1014
• 15 Parmentier S, McGregor L, Catimel B, Leung LLK, McGregor JL. Inhibition of platelet function by a monoclonal antibody (LYP20) directed against a granule membrane glycoprotein (GMP-140/PADGEM). Blood 1991; 77: 1734-1739
• 16 Murphy JF, McGregor JL. Two sites on P-selectin are involved in mediating the adhesion of monocytes to activated endothelial cells. Thromb Haemost 1993; 69: 1362
• 17 Winocour PD, Chignier E, Parmentier S, McGregor JL. A monoclonal antibody (LYP20) directed against GMP-140/PADGEM in human platelets binds to thrombin-stimulated rat platelets in vitro. Comp Biochem Physiol 1992; 102 (02) 231-236
• 18 George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986; 78: 340-348
• 19 Palabrica TM, Furie BC, Konstam MA, Aronovitz MJ, Connoly R, Brockway BA, Ramberg KL, Furie B. Thrombus imaging in a primate model with antibodies specific for an external membrane protein of activated platelets. Proc Natl Acad Sci USA 1989; 86: 1036-1045
• 20 Dechavanne M, Ffrench M, Pages J, Ffrench P, Boukerche H, Bryon PA, McGregor JL. Significant reduction in the binding of a monoclonal antibody (LYP18) directed against the Ilb/IIa glycoprotein complex to platelets of patients having undergone extracorporeal circulation. Thromb Haemost 1987; 57: 106-109
• 21 Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990; 75: 128-138
• 22 Inokuchi K. Thrombogenic properties at the site of vascular anastomosis studied by a new technique for measuring platelet adherence. Surgery 1961; 50: 493-499
• 23 Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987; 70: 307-315
• 24 Metzelaar MJ, Sixma JJ, Nieuwenhuis HK. Detection of platelet activation using activation specific monoclonal antibodies. Blood Cells 1990; 16: 85-96
• 25 Corash L. Measurement of platelet activation by fluorescence-activated flow cytometry. Blood Cells 1990; 160: 97-108
• 26 Johnston GI, Pickett EB, McEver RP, George JN. Heterogeneity of platelet secretion in response to thrombin demonstrated by fluorescence flow cytometry. Blood 1987; 69: 1401-1403
• 27 Marti GE, Magruder L, Schuette WE, Gralnick HR. Flow cytometric analysis of platelet surface antigens. Cytometry 1988; 9: 448-455
• 28 Tschope D, Rosen P, Schiwippert B, Kehrel B, Schauseil S, Esser J, Gries FA. Platelet analysis using flowcytometric procedures. Platelets 1990; 1: 127-133
• 29 Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardio-pul monary bypass induces leukocyte-platelet adhesion. Blood 1992; 79: 1201-1205
• 30 Scharf RE, Tomer A, Teirstein P, Ruggeri ZM, Harker LA. Flow cytometric analysis of activated circulating platelets detected during percutaneous transluminal coronary angioplasty. Blood 1989; 74: 32a
• 31 Janes SL, Wilson DJ, Chronos N, Goodall AH. Evaluation of whole blood flow cytometry detection of platelet bound fibrinogen on normal subjects and patients with activated platelets. Thromb Haemost 1993; 70: 659-666
• 32 Abrams C, Shattil JS. Immunological detection of activated platelets in clinical disorders. Thromb Haemost 1991; 65: 467-473
• 33 Smith D, Sanjar S, Herd C, Morley J. In vivo method for assessment of platelet accumulation. J Pharm Met 1989; 21: 45-59
• 34 Issekutz AC, Ripley M, Jackson JR. Role of neutrophils in the deposition of platelets during acute inflammation. Lab Invest 1983; 49: 716-724
• 35 Cieslar P, Greenberg JP, Rand ML, Packman MA, Kinlough-Rathbone RL, Mustard JF. Separation of thrombin treated platelets by density gradient centrifugation. Blood 1979; 53: 867-874
• 36 Van Oost B, van Hien-Haggg IH, Timmermans APM, Sixma JJ. The effect of thrombin on the density distribution of blood platelets: detection of activated platelets in the circulation. Blood 1983; 62: 433-438